These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31162310)

  • 1. Management of Multiple Sclerosis Relapses.
    Repovic P
    Continuum (Minneap Minn); 2019 Jun; 25(3):655-669. PubMed ID: 31162310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of relapses of multiple sclerosis (a review)].
    Brkovich RR; Totolian NA; Sokolov AIu; Ignatov IuD; Skoromets AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10 Pt 2):69-77. PubMed ID: 24416811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Multiple Sclerosis Relapse.
    Berkovich RR
    Continuum (Minneap Minn); 2016 Jun; 22(3):799-814. PubMed ID: 27261683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange in severe acute relapses of multiple sclerosis - Results from a Portuguese cohort.
    Correia I; Ribeiro JJ; Isidoro L; Batista S; Nunes C; Macário C; Borges C; Tomaz J; Sousa L
    Mult Scler Relat Disord; 2018 Jan; 19():148-152. PubMed ID: 29241141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients who have relapses in multiple sclerosis.
    Williams G
    Br J Nurs; 2004 Sep 23-Oct 13; 13(17):1012-6. PubMed ID: 15549010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute relapses in multiple sclerosis.
    Berkovich R
    Neurotherapeutics; 2013 Jan; 10(1):97-105. PubMed ID: 23229226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive Multiple Sclerosis.
    Willis MA; Fox RJ
    Continuum (Minneap Minn); 2016 Jun; 22(3):785-98. PubMed ID: 27261682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids in the treatment of multiple sclerosis.
    Myhr KM; Mellgren SI
    Acta Neurol Scand Suppl; 2009; (189):73-80. PubMed ID: 19566504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.
    Köpke S; Kasper J; Mühlhauser I; Nübling M; Heesen C
    Mult Scler; 2009 Jan; 15(1):96-104. PubMed ID: 18845657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review.
    Kalincik T
    Neuroepidemiology; 2015; 44(4):199-214. PubMed ID: 25997994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early relapses, onset of progression, and late outcome in multiple sclerosis.
    Scalfari A; Neuhaus A; Daumer M; Deluca GC; Muraro PA; Ebers GC
    JAMA Neurol; 2013 Feb; 70(2):214-22. PubMed ID: 23407713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing outcomes from clinical studies of oral disease-modifying therapies (dimethyl fumarate, fingolimod, and teriflunomide) in relapsing MS: Assessing absolute differences using a number needed to treat analysis.
    Freedman MS; Montalban X; Miller AE; Dive-Pouletty C; Hass S; Thangavelu K; Leist TP
    Mult Scler Relat Disord; 2016 Nov; 10():204-212. PubMed ID: 27919491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse management in multiple sclerosis.
    Thrower BW
    Neurologist; 2009 Jan; 15(1):1-5. PubMed ID: 19131851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Multiple Sclerosis.
    Ontaneda D
    Continuum (Minneap Minn); 2019 Jun; 25(3):736-752. PubMed ID: 31162314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses].
    de Andrés C; Anaya F; Giménez-Roldán S
    Rev Neurol; 2000 Apr 1-15; 30(7):601-5. PubMed ID: 10859735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise in the management of multiple sclerosis relapses: current evidence and future perspectives.
    Rooney S; Albalawi H; Paul L
    Neurodegener Dis Manag; 2020 Apr; 10(2):103-115. PubMed ID: 32352357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the Choosing Wisely
    Trumbic B; Zéphir H; Ouallet JC; Le Page E; Laplaud D; Bensa C; de Sèze J
    Rev Neurol (Paris); 2018; 174(1-2):28-35. PubMed ID: 29128151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients-A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness.
    Ehler J; Blechinger S; Rommer PS; Koball S; Mitzner S; Hartung HP; Leutmezer F; Sauer M; Zettl UK
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.
    Nazareth TA; Rava AR; Polyakov JL; Banfe EN; Waltrip Ii RW; Zerkowski KB; Herbert LB
    Mult Scler Relat Disord; 2018 Nov; 26():219-234. PubMed ID: 30368080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.